212 related articles for article (PubMed ID: 1711929)
1. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals.
Jasin HE
Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929
[TBL] [Abstract][Full Text] [Related]
2. In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I and pokeweed mitogen: the contribution of CD5+ (Leu 1) B cells.
Karsh J; Goldstein R; Lazarovits AI
Clin Exp Immunol; 1989 Aug; 77(2):179-83. PubMed ID: 2476269
[TBL] [Abstract][Full Text] [Related]
3. High levels of in vitro IgM rheumatoid factor synthesis correlate with HLA-DR4 in normal individuals.
Olsen NJ; Stastny P; Jasin HE
Arthritis Rheum; 1987 Aug; 30(8):841-8. PubMed ID: 3498492
[TBL] [Abstract][Full Text] [Related]
4. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
Suzuki N; Sakane T; Engleman EG
J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
[TBL] [Abstract][Full Text] [Related]
5. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.
Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H
Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131
[TBL] [Abstract][Full Text] [Related]
6. In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.
Olsen N; Ziff M; Jasin HE
Rheumatol Int; 1982; 2(2):59-66. PubMed ID: 6983711
[TBL] [Abstract][Full Text] [Related]
7. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.
Keogan MT; Callaghan M; Yanni G; Mulherin D; Feighery C; Brown DL; Fitzgerald MX; Bresnihan B
Clin Exp Immunol; 1993 Mar; 91(3):462-6. PubMed ID: 7680296
[TBL] [Abstract][Full Text] [Related]
9. Changes in peripheral blood CD5 (Bla) B-cell populations and autoantibodies following blood transfusion.
Paglieroni TG; Ward J; Holland PV
Transfusion; 1995 Mar; 35(3):189-98. PubMed ID: 7533341
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous IgM autoantibody production in vitro by B lymphocytes of normal human neonates.
Barbouche R; Forveille M; Fischer A; Avrameas S; Durandy A
Scand J Immunol; 1992 Jun; 35(6):659-67. PubMed ID: 1376488
[TBL] [Abstract][Full Text] [Related]
11. In vitro IgM rheumatoid-factor production induced by tetanus toxoid.
Levinson AI; Tar L
J Allergy Clin Immunol; 1988 Apr; 81(4):730-6. PubMed ID: 3258604
[TBL] [Abstract][Full Text] [Related]
12. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
Jones BM; Cheng IK; Wong RW
Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis.
Xu H; Geddes R; Roberts-Thomson PJ
Ann Rheum Dis; 1994 Jun; 53(6):383-90. PubMed ID: 7518662
[TBL] [Abstract][Full Text] [Related]
14. In vitro IgG rheumatoid factor production by CD5-negative murine B cells in response to immune complexes of lipopolysaccharide.
Taguchi H; Kanoh M; Takubo N; Kadota S; Kanazawa K; Shibata T; Utsumi S
Clin Exp Immunol; 1990 Oct; 82(1):128-32. PubMed ID: 1698578
[TBL] [Abstract][Full Text] [Related]
15. B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S
Br J Haematol; 1991 Aug; 78(4):474-9. PubMed ID: 1716955
[TBL] [Abstract][Full Text] [Related]
16. Frequency analysis of human peripheral blood B cells producing IgM-rheumatoid factor. Differential effects of stimulation with monoclonal antibodies to CD3 and Staphylococcus aureus.
Hirohata S; Inoue T; Miyamoto T
J Immunol; 1990 Sep; 145(6):1681-6. PubMed ID: 2144005
[TBL] [Abstract][Full Text] [Related]
17. In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis.
Nonaka S; Yasuda M; Nobunaga M
J Rheumatol; 1993 Sep; 20(9):1478-84. PubMed ID: 7513025
[TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.
Kasaian MT; Ikematsu H; Casali P
J Immunol; 1992 May; 148(9):2690-702. PubMed ID: 1374094
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD5 antigen expression.
Inghirami G; Foitl DR; Sabichi A; Zhu BY; Knowles DM
Blood; 1991 Sep; 78(6):1503-15. PubMed ID: 1715792
[TBL] [Abstract][Full Text] [Related]
20. In vivo T cell depletion in rheumatoid arthritis is associated with increased in vitro IgM-rheumatoid factor synthesis.
Olsen NJ; Teal GP; Strand V
Clin Immunol Immunopathol; 1993 May; 67(2):124-9. PubMed ID: 7686090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
